loadpatents
name:-0.014485120773315
name:-0.0087869167327881
name:-0.0011389255523682
Vatner; Stephen F. Patent Filings

Vatner; Stephen F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vatner; Stephen F..The latest application filed is for "methods and compositions for providing cardiac protection".

Company Profile
0.10.12
  • Vatner; Stephen F. - New York NY
  • Vatner; Stephen F. - Barnegat Light NJ
  • Vatner; Stephen F. - Barnegat Lgt NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-sense microrna expression vectors
Grant 9,051,568 - Abellatif , et al. June 9, 2
2015-06-09
Methods and compositions for providing cardiac protection
Grant 8,871,735 - Vatner , et al. October 28, 2
2014-10-28
Methods And Compositions For Providing Cardiac Protection
App 20130131005 - Vatner; Stephen F. ;   et al.
2013-05-23
Methods and compositions for treating obesity and related disorders
Grant 8,440,640 - Vatner May 14, 2
2013-05-14
Adenylyl cyclase antibodies, compositions and uses thereof
Grant 8,263,401 - Vatner , et al. September 11, 2
2012-09-11
Methods and Compositions for Treating Obesity and Related Disorders
App 20110230435 - Vatner; Stephen F.
2011-09-22
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
App 20110124714 - Depre; Christophe ;   et al.
2011-05-26
Anti-sense Microrna Expression Vectors
App 20110105592 - Abdellatif; Maha ;   et al.
2011-05-05
Methods and compositions for providing cardiac protection
App 20110021453 - Vatner; Stephen F. ;   et al.
2011-01-27
Method for identifying agents which modulate cell growth or survival
Grant 7,846,683 - Vatner , et al. December 7, 2
2010-12-07
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
Grant 7,803,908 - Depre , et al. September 28, 2
2010-09-28
Adenylyl Cyclase Antibodies, Compositions and Uses Thereof
App 20080274103 - Vatner; Stephen F. ;   et al.
2008-11-06
Method for Identifying Agents Which Modulate Cell Growth or Survival
App 20080096237 - Vatner; Stephen F. ;   et al.
2008-04-24
MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
App 20070275099 - Vatner; Stephen F. ;   et al.
2007-11-29
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
App 20070270338 - Depre; Christophe ;   et al.
2007-11-22
Mst1 modulation of apoptosis in cardiac tissue and modulators of Mst1 for treatment and prevention of cardiac disease
Grant 7,160,859 - Vatner , et al. January 9, 2
2007-01-09
Regulation of type 5 adenylyl cyclase for treatment of neurodegenerative and cardiac diseases
App 20060252774 - Vatner; Stephen F.
2006-11-09
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
Grant 7,009,038 - Depre , et al. March 7, 2
2006-03-07
Mst1 modulation of apoptosis in cardiac tissue and modultors of Mst1 for treatment and prevention of cardiac disease
App 20040213794 - Vatner, Stephen F. ;   et al.
2004-10-28
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
App 20040009513 - Depre, Christophe ;   et al.
2004-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed